Antidepressant use prior to traumatic brain injury was not associated with worse short-term outcomes for individuals ...
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention using third-generation stents remained noninferior vs. 12-month DAPT for non-ST-segment elevation myocardial infarction ...
The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results